IMMUNOTECH
IMMUNOTECH is a company registered under SIREN number 322904079, with its registered office in MARSEILLE. Its main activity falls under the sector: Scientific research and development. It has 3 establishments. 3 serving directors are recorded in the national business register. Its reported revenue for the financial year ended in 2025 is 66,484,632 euros.
Sources: INSEE Sirene, INPI RNE, INPI, annual accounts.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- 250 to 499 employees
- Created
- 16 Oct 1981
- Share capital
- 8,109,480.00 EUR
- Registered with the trade register
- 30 Aug 1983
- Financial year end
- 31/12
- Establishments
- 3
Directors
- ERNST & YOUNG AUDIT Commissaire aux comptes titulaire
- Information not disclosable Commissaire aux comptes suppleant
- Sylvain LE MARCHAND 51 years old, 10/1975 President de SAS
Establishments
-
32290407900025 13009 MARSEILLE
-
32290407900066 13009 MARSEILLE
Financial strength
Financial score
70 / 100 B
Confidence: high · computed on the financial year ended 31 Dec 2025
- Equity to assets (73.4 %)
- 24.9 out of 30
- EBITDA margin (24.4 %)
- 19.6 out of 25
- Liquidity (147.8 %)
- 6.0 out of 20
- Debt (0.0 %)
- 15.0 out of 15
- Revenue trend (4.7 %)
- 4.9 out of 10
formula fin-1.0
Legal score
100 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (45.1 years)
- 20.0 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2025 | 66,484,632 € | +4.7 % | 16,228,294 € | 31,971,000 € |
| 31 Dec 2024 | 63,496,989 € | +11.5 % | 15,437,740 € | 8,794,396 € |
| 31 Dec 2023 | 56,923,470 € | -8.1 % | 12,061,852 € | 8,873,172 € |
| 31 Dec 2022 | 61,932,534 € | +5.3 % | 16,223,928 € | 10,646,808 € |
| 31 Dec 2021 | 58,816,219 € | -2.7 % | 14,237,657 € | 8,060,005 € |
| 31 Dec 2020 | 60,477,558 € | +11.4 % | 12,646,477 € | 11,223,520 € |
| 31 Dec 2019 | 54,300,418 € | +18.4 % | 15,665,596 € | 7,443,864 € |
| 31 Dec 2018 | 45,863,567 € | +4.3 % | 12,518,573 € | 5,671,236 € |
| 31 Dec 2017 | 43,958,763 € | +15.8 % | 12,527,507 € | 6,105,774 € |
| 31 Dec 2016 | 37,971,953 € | first year on record | 9,379,608 € | 11,961,418 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
- ART OFF BBS ASSOCIATION DE RECHERCHE TRANSDISCIPLINAIRE POUR L OBSERVATION ET LA FORMATION AUPRES DES FAMILLES ET DES
- FLOATERS ( FATHOM LIFE ORIGIN THROUGH ATMOSPHERIC TRAINING, EXPLORATION, AND RESEARCH STUDIES)
- INFORMATIQUE COMMUNALE REGION MEDITERRAN
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT
- NICOLAS JARMUZYNSKI
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la fabrication et du commerce des produits à usage pharmaceutique, parapharmaceutique et vétérinaire du 1er juin 1989. Etendue par arrêté du 20 avril 1990 JORF 29 avril 1990
IDCC 1555 · repealed · 1 establishment · declared in August 2026
Labels and certifications
Gender equality index
-
Gender equality index 2025
90 out of 100
-
Gender equality index 2024
93 out of 100
-
Gender equality index 2023
95 out of 100
-
Gender equality index 2022
90 out of 100
-
Gender equality index 2021
90 out of 100
Legal notices
-
Amendment 8 Nov 2026
- Court :
- Greffe du Tribunal des Activités Economiques de Marseille
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20260215, annonce n 331 · Proof of publication (PDF)
-
Filing of accounts 24 Jul 2026
- Court :
- Greffe du Tribunal des Activités Economiques de marseille
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2025
BODACC C n 20260139, annonce n 744 · Proof of publication (PDF)
-
Filing of accounts 28 Aug 2025
- Court :
- Greffe du Tribunal des Activités Economiques de marseille
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250164, annonce n 1070 · Proof of publication (PDF)
-
Filing of accounts 21 Nov 2024
- Court :
- Greffe du Tribunal de Commerce de marseille
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20240225, annonce n 815 · Proof of publication (PDF)
-
Filing of accounts 22 Nov 2023
- Court :
- Greffe du Tribunal de Commerce de marseille
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20230225, annonce n 874 · Proof of publication (PDF)
-
Amendment 7 Sep 2022
- Court :
- Greffe du Tribunal de Commerce de Marseille
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20220173, annonce n 268 · Proof of publication (PDF)
-
Filing of accounts 7 Sep 2022
- Court :
- Greffe du Tribunal de Commerce de marseille
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20220173, annonce n 474 · Proof of publication (PDF)
-
Filing of accounts 23 Aug 2022
- Court :
- Greffe du Tribunal de Commerce de marseille
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2019
BODACC C n 20220162, annonce n 402 · Proof of publication (PDF)
-
Filing of accounts 23 Aug 2022
- Court :
- Greffe du Tribunal de Commerce de marseille
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2020
BODACC C n 20220162, annonce n 403 · Proof of publication (PDF)
-
Amendment 4 Jul 2021
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE MARSEILLE
- Amendment :
- transfert du siège social.
BODACC B n 20210129, annonce n 420 · Proof of publication (PDF)
-
Filing of accounts 6 Mar 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE MARSEILLE
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2017
BODACC C n 20200047, annonce n 439 · Proof of publication (PDF)
-
Filing of accounts 6 Mar 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE MARSEILLE
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2018
BODACC C n 20200047, annonce n 440 · Proof of publication (PDF)
Filings and accounts
- Formality 4 Nov 2026
- Formality 14 Aug 2026
Change history
- officer_removed President de SAS → (empty) 5 Nov 2026
- officer_removed Commissaire aux comptes titulaire → (empty) 5 Nov 2026
- officer_appointed (empty) → Commissaire aux comptes titulaire 5 Nov 2026
- officer_appointed (empty) → President de SAS 5 Nov 2026
- officer_appointed (empty) → Commissaire aux comptes titulaire 9 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- officer_appointed (empty) → Commissaire aux comptes suppleant 9 Oct 2026
- registered_address (empty) → 130 Avenue de Lattre de Tassigny 13276 Marseille 9e Arrondissement Cedex 09 3 Oct 2026
Frequently asked questions about IMMUNOTECH
- What is the SIREN number of IMMUNOTECH?
- The SIREN number of IMMUNOTECH is 322904079. Its intra-community VAT number is FR21322904079.
- Where is the head office of IMMUNOTECH?
- Head office address: 130 AVENUE DE LATTRE DE TASSIGNY, 13009 MARSEILLE.
- When was IMMUNOTECH founded?
- IMMUNOTECH was founded on 16 Oct 1981.
- What does IMMUNOTECH do?
- Its declared main activity is: Research and experimental development on biotechnology (NAF code 72.11Z).
- Who runs IMMUNOTECH?
- The officers listed in the register are ERNST & YOUNG AUDIT (Commissaire aux comptes titulaire), Sylvain LE MARCHAND (President de SAS).
- What is the revenue of IMMUNOTECH?
- The latest published revenue is 66,484,632 €, for the 2025 financial year.
- How many employees does IMMUNOTECH have?
- The declared headcount is 250 to 499 employees. Insee data for 2024.
- Is IMMUNOTECH subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.